Operator: Greetings and welcome to Inhibikase Therapeutics First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ETBOSTON and ATLANTA, May 15, 2024 Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing.
Meeting to discuss potential of IkT-001Pro as a disease modifying treatment for Pulmonary Arterial HypertensionBOSTON and ATLANTA, April 03, 2024 Inhibikase Therapeutics, Inc. , a.
Inhibikase Therapeutics (IKT) Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.